Metastatic Renal Cell Cancer
Information
- Disease name
- Metastatic Renal Cell Cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01590069 | Active, not recruiting | Phase 1 | Aerosolized Aldesleukin in Treating Patients With Lung Metastases | June 28, 2012 | April 30, 2026 |
| NCT03092856 | Active, not recruiting | Phase 2 | Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer | July 19, 2017 | July 19, 2025 |
| NCT01767636 | Active, not recruiting | Phase 2 | Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer | May 16, 2013 | November 16, 2024 |
| NCT02664883 | Active, not recruiting | Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer | September 8, 2015 | September 8, 2024 | |
| NCT01462214 | Completed | Phase 1/Phase 2 | Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer | October 2011 | January 2017 |
| NCT01522820 | Completed | Phase 1 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | March 2012 | July 2016 |
| NCT01743469 | Completed | Phase 2 | A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers | December 2012 | April 2016 |
| NCT01829841 | Completed | Phase 2 | A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer | May 2011 | May 2016 |
| NCT03229278 | Completed | Phase 1 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | October 3, 2017 | October 30, 2022 |
| NCT00428220 | Completed | N/A | A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. | July 2007 | September 2014 |
| NCT01246843 | Completed | Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib | July 2009 | April 2011 | |
| NCT01258348 | Completed | Phase 1 | A Phase 1b Trial in Patients With Renal Cell Cancer | July 2008 | February 2012 |
| NCT02579811 | Completed | Phase 2 | Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer | December 30, 2015 | June 20, 2023 |
| NCT02599194 | Completed | Phase 2 | 18F-FSPG PET/CT for Cancer Patients on Therapy | July 2015 | December 14, 2016 |
| NCT02626130 | Completed | Early Phase 1 | Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer | March 30, 2016 | June 20, 2022 |
| NCT02843607 | Completed | Phase 1/Phase 2 | Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer | July 1, 2016 | July 1, 2019 |
| NCT02899078 | Completed | Phase 1/Phase 2 | Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer | November 15, 2016 | February 24, 2021 |
| NCT00027820 | Completed | Phase 1/Phase 2 | Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | August 2001 | September 5, 2004 |
| NCT01926990 | Completed | Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma | August 2014 | December 17, 2021 | |
| NCT02318771 | Completed | Phase 1 | Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer | February 5, 2015 | March 25, 2021 |
| NCT02555748 | Completed | Phase 4 | Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma | November 17, 2015 | January 16, 2020 |
| NCT00655252 | No longer available | Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy | |||
| NCT00670748 | Terminated | Phase 2 | Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer | May 29, 2008 | June 29, 2016 |
| NCT02089334 | Terminated | Phase 1/Phase 2 | Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer | August 2014 | May 17, 2018 |
| NCT02542202 | Terminated | N/A | Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | May 1, 2015 | March 23, 2023 |
| NCT01884961 | Unknown status | Phase 2 | Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2 | July 9, 2012 | June 2022 |
| NCT02689167 | Unknown status | Phase 2 | Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma | February 19, 2016 | February 2024 |